Cite

HARVARD Citation

    Lei, Y. et al. (n.d.). P12 TLR8 agonist VTX-2337 sensitizes head and neck cancer cells to cetuximab. Oral oncology. 51 (5), pp. e46-. [Online]. 
  
Back to record